Facebook
Twitter
LinkedIn
ForwardUrologic Care for the Advanced Practice Provider Webcast (2020)
COMPLIMENTARY WEBCAST FOR AUA MEMBERS!
LED BY COURSE DIRECTORS, ANNE CALVARESI, DNP, CRNP AND JIM KOVARIK, PA-C, THIS WEBCAST FEATURES INTERACTIVE, CLINICALLY RELEVANT PROGRAMMING DEVELOPED BY APPS FOR APPS! TOPICS INCLUDE:
- Oncology
- Technology and Pharmacology
- Urolithiasis
- Infections/Inflammations
- Men’s Health
- Voiding Dysfunction
- Best Practices and Practice Integration: An APP Practice Management Panel Discussion
Visit the program tab for full details.
Target Audience
- Physician Assistants
- Advanced Practice Nurses
- Registered Nurses
- Allied Health Care Professionals
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Define active surveillance and identify appropriate candidates and discuss tools & templates for active surveillance and triggers to discontinue active surveillance.
- Recognize and explain the appropriate treatment and follow-up for patients with superficial bladder cancer.
- Outline an approach to telehealth for APPs.
- Utilize available perioperative risk stratification tools to assess thromboembolic risk and bleeding risk in patients taking antithrombotic medications in order to develop a perioperative antithrombotic management plan for elective surgeries.
- Identify and discuss the management of complex nephrolithiasis cases.
- Comprehend and recognize the differential diagnosis and evaluation algorithm for patients with micro and macroscopic hematuria presenting in the office setting.
- Discuss what is and is not classified as a complicated UTI and the evaluation and management of those infections.(
- Ascertain the concept of shared decision making for the evaluation and treatment of Erectile Dysfunction (ED).
- Analyze the latest evidence on the surgical management of lower urinary tract symptoms associated with benign prostatic hyperplasia or BPH/LUTS.
- Differentiate between storage or emptying in a neurogenic bladder in order to properly treat and prevent complications.
- Identify mechanisms and risks associated with 3rd line treatment options for overactive bladder.
- Identify common problems associated with neurogenic and overactive bladder.
- Discuss optimal utilization of urologic Advanced Practice Providers.
Session I: Oncology
- Welcome/Introduction: Anne Calvaresi, DNP, CRNP; Jim Kovarik, PA-C
- Prostate Cancer: Active Surveillance Management: Jim Kovarik, PA-C
- Abstract Presentation: Assessing Quality and Safety of an Advanced Practice Provider led Active Surveillance Clinic for Men with Prostate Cancer – Xin Lin, NP
- Role of Genetics for Urologic Cancers: Leonard G. Gomella, MD, FACS
- Diagnosis and Management of Superficial Bladder Cancer: Anne Calvaresi, DNP, CRNP
- Podium Presentation – Testicular Mass in a Prostate Cancer Survivor: Diagnosis Management – Mary Dunn, MSN, RN, OCN, NP-C
- Podium Presentation – GU Hereditary Genetic Counseling and Testing: Prostate Kidney and Bladder Cancer, Oh My! – Lindsey Byrne, MS, LGC
- AUAUniversity Demo for the NEW APP Curriculum: Mary Dunn, MSN, RN, OCN, NP-C
Session II: Technology & Pharmacology
- Telehealth in Urology Practice: Stanley Mukundi, PA-C
- Perioperative Antithrombotic Therapy Management: Sarah Stanley, PA-C
- Podium Presentation – Advocacy and the Advanced Practice Provider: Why State and Federal Advocacy Should be an Integral Component of Your Professional Life – Adele Caruso, DNP, CRNP
- Podium Presentation – Decreasing Post-Operative Opioid Use While Simultaneously Managing Pain: A Prospective Study of Men Who Underwent Scrotal Surgery – Libert Ramos, DNP, MSN/Ed, APRN
- Podium Presentation – Changes & Challenges and Tips & Tricks to Assisting in Single-Port Robotics Cases – Ashleigh Renitsky, PA-C
Session III: Urolithiasis
- Challenging Urolithiasis Case Panel Discussion
- Moderator: Anne Calvaresi, DNP, CRNP
- Panelists: Jim Kovarik, PA-C; Leslie Lorbacher, NP
- Pediatric Urology 101: Heidi A. Stephany, MD
- Podium Presentation – Transition Care for the Young Adult with Congenital Urologic Conditions – Rachel Shapiro, PA-C
Session IV: Infections/Inflammation
- Welcome: Anne Calvaresi, DNP, CRNP; Jim Kovarik, PA-C
- Evaluation of the Patient with Hematuria in 2020: The New Guidelines and Beyond: Jay D. Raman, MD, FACS
- Complicated UTI Management: Brooke Zilinskas, PA-C
Session V: Men’s Health
- Guidelines Based Medical Management and Effective Treatment of Erectile Dysfunction: Kenneth Mitchell, MPAS, PA-C
- BPH Debate: Bipolar TURP vs. HoLEP
- Moderator: Anne Calvaresi, DNP, CRNP
- Panelists: Kerri L. Thurmon, MD, MPH; Kevin McVary, MD, FACS
- Podium Presentation: Pelvic Muscle Rehabilitation following RP: Merging Research with Clinical Practice – Diane Newman, DNP, ANP-BC, FAAN, BCB-PMD
- NEW Award Presentation: Advanced Practice Provider of the Year: Tricia Zubert, NP and Chair, APP Membership Committee
Session VI: Voiding Dysfunction
- Neurogenic Bladder: To Pee or Not to Pee, that is the Question... - Lori Guelman, APN
- Treatment Options for Refractory OAB: Alana Murphy, MD
- Neurogenic Bladder and Overactive Bladder Case Panel Discussion
- Moderator: Jim Kovarik, PA-C
- Panelists: Lori Guelman, APN; Alana Murphy, MD
- Podium Presentation – The Use of Peripheral Tibial Nerve Stimulation (PTNS) as an Alternative Treatment for OAB/Incontinence – Lynn Allmond, FNP-BC, CCRC
- Podium Presentation – Caring for the Patient with an Orthotropic Neobladder Urinary Diversion – Kevin Wayne, PA-C
Session VII: Best Practices and Practice Integration: An APP Practice Management Panel Discussion
- Best Practices and Practice Integration: An APP Practice Management Panel Discussion
- Moderator: Jim Kovarik, PA-C
- Panelists: Anne Calvaresi, DNP, CRNP; Kenneth Mitchell, MPAS, PA-C; Edouard J. Trabulsi, MD, FACS
- Closing Remarks/ Course Adjourns: Anne Calvaresi, DNP, CRNP; Jim Kovarik, PA-C
Education Council Disclosures
AUA Office of Education Staff has nothing to disclose.
Course Co-director(s)
James Kovarik, MD
has a financial relationship (Stock) with Johnson & Johnson;.
has a financial relationship (Stock) with Johnson & Johnson;.
has a financial relationship (Employment) with Urological Association of Physician Assistants;.
has a financial relationship (Employment) with Urological Association of Physician Assistants;.
has a financial relationship (Stock) with Allergan;.
has a financial relationship (Stock) with Allergan;.
has a financial relationship (Stock) with Becton Dickinson & Co;.
has a financial relationship (Stock) with Becton Dickinson & Co;.
has a financial relationship (Stock) with CVS Caremark;.
has a financial relationship (Stock) with CVS Caremark;.
has a financial relationship (Stock) with Abbvie;.
has a financial relationship (Stock) with Abbvie;.
has a financial relationship (Stock) with CVS Caremark;.
has a financial relationship (Stock) with CVS Caremark;.
has a financial relationship (Stock) with Johnson & Johnson;.
has a financial relationship (Stock) with Johnson & Johnson;.
has a financial relationship (Employment) with Urological Association of Physician Assistants;.
has a financial relationship (Employment) with Urological Association of Physician Assistants;.
has a financial relationship (Stock) with Allergan;.
has a financial relationship (Stock) with Allergan;.
has a financial relationship (Stock) with Becton Dickinson & Co;.
has a financial relationship (Stock) with Becton Dickinson & Co;.
has a financial relationship (Stock) with CVS Caremark;.
has a financial relationship (Stock) with CVS Caremark;.
has a financial relationship (Stock) with Abbvie;.
has a financial relationship (Stock) with Abbvie;.
has a financial relationship (Stock) with CVS Caremark;.
has a financial relationship (Stock) with CVS Caremark;.
has a financial relationship (Stock) with Pfizer;.
has a financial relationship (Stock) with Pfizer;.
has a financial relationship (Stock) with Abbvie;.
has a financial relationship (Stock) with Abbvie;.
has a financial relationship (Stock) with Allergan;.
has a financial relationship (Stock) with Allergan;.
has a financial relationship (Stock) with Pfizer;.
has a financial relationship (Stock) with Pfizer;.
has a financial relationship (Stock) with Zimmer Holdings Inc;.
has a financial relationship (Stock) with Zimmer Holdings Inc;.
has a financial relationship (Stock) with Johnson & Johnson;.
has a financial relationship (Stock) with Johnson & Johnson;.
has a financial relationship (Stock) with Becton Dickinson & Co;.
has a financial relationship (Stock) with Becton Dickinson & Co;.
has a financial relationship (Stock) with Pfizer;.
has a financial relationship (Stock) with Abbvie;.
has a financial relationship (Stock) with Abbvie;.
has a financial relationship (Stock) with Allergan;.
has a financial relationship (Stock) with Allergan;.
has a financial relationship (Stock) with Pfizer;.
has a financial relationship (Stock) with Pfizer;.
has a financial relationship (Stock) with Zimmer Holdings Inc;.
has a financial relationship (Stock) with Zimmer Holdings Inc;.
has a financial relationship (Stock) with Johnson & Johnson;.
has a financial relationship (Stock) with Johnson & Johnson;.
has a financial relationship (Stock) with Becton Dickinson & Co;.
has a financial relationship (Stock) with Becton Dickinson & Co;.
has a financial relationship (Stock) with Pfizer;.
Anne Lizardi-Calvaresi, NP
has no relevant financial relationships to disclose at this time.
Faculty(s)
Lynn Allmond, NP
has no relevant financial relationships to disclose at this time.
Kerri Barnes, MD
has a financial relationship (Other) with Lumenis;.
has a financial relationship (Other) with Lumenis;.
has a financial relationship (Other) with Lumenis;.
has a financial relationship (Other) with Lumenis;.
Adele Caruso, MD
has no relevant financial relationships to disclose at this time.
Mary Dunn, MD
has no relevant financial relationships to disclose at this time.
Leonard Gomella, MD
has a financial relationship (Employment) with McGraw Hill;.
has a financial relationship (Independent contractor) with Strand laboratories;.
has a financial relationship (Independent contractor) with Merck Pharmaceuticals;.
has a financial relationship (Employment) with Wolters Kluwer;.
has a financial relationship (Independent contractor) with Strand laboratories;.
has a financial relationship (Employment) with Canadian Journal of Urology;.
has a financial relationship (Independent contractor) with Merck Pharmaceuticals;.
has a financial relationship (Employment) with McGraw Hill;.
has a financial relationship (Employment) with Wolters Kluwer;.
has a financial relationship (Employment) with Canadian Journal of Urology;.
has a financial relationship (Employment) with Merck Manual;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with Bayer;.
has a financial relationship (Independent contractor) with MDx Health;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Bayer;.
has a financial relationship (Employment) with Merck Manual;.
has a financial relationship (Independent contractor) with MDx Health;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with Bayer;.
has a financial relationship (Independent contractor) with MDx Health;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Bayer;.
has a financial relationship (Employment) with Merck Manual;.
has a financial relationship (Independent contractor) with MDx Health;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Employment) with Merck Manual;.
has a financial relationship (Employment) with McGraw Hill;.
has a financial relationship (Independent contractor) with Strand laboratories;.
has a financial relationship (Independent contractor) with Merck Pharmaceuticals;.
has a financial relationship (Employment) with Wolters Kluwer;.
has a financial relationship (Independent contractor) with Strand laboratories;.
has a financial relationship (Employment) with Canadian Journal of Urology;.
has a financial relationship (Independent contractor) with Merck Pharmaceuticals;.
has a financial relationship (Employment) with McGraw Hill;.
has a financial relationship (Employment) with Wolters Kluwer;.
has a financial relationship (Employment) with Canadian Journal of Urology;.
Lori Guelman, MD
has a financial relationship (Independent contractor) with ODx;.
has a financial relationship (Independent contractor) with ODx;.
has a financial relationship (Independent contractor) with ODx;.
has a financial relationship (Independent contractor) with ODx;.
Xin Lin, MD
has no relevant financial relationships to disclose at this time.
Leslie Lorbacher, MD
has no relevant financial relationships to disclose at this time.
Kevin McVary, MD
has a financial relationship (Independent contractor) with Olympus;.
has a financial relationship (Other) with Olympus;.
has a financial relationship (Other) with NIDDK;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Other) with Olympus;.
has a financial relationship (Independent contractor) with Olympus;.
has a financial relationship (Other) with NIDDK;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Other) with Olympus;.
has a financial relationship (Employment) with SRS Medical Systems;.
has a financial relationship (Other) with NxThera;.
has a financial relationship (Other) with Astellas;.
has a financial relationship (Other) with Olympus;.
has a financial relationship (Other) with NxThera;.
has a financial relationship (Employment) with SRS Medical Systems;.
has a financial relationship (Other) with Astellas;.
has a financial relationship (Other) with Olympus;.
has a financial relationship (Employment) with SRS Medical Systems;.
has a financial relationship (Other) with NxThera;.
has a financial relationship (Other) with Astellas;.
has a financial relationship (Other) with Olympus;.
has a financial relationship (Other) with NxThera;.
has a financial relationship (Employment) with SRS Medical Systems;.
has a financial relationship (Other) with Astellas;.
has a financial relationship (Independent contractor) with Olympus;.
has a financial relationship (Other) with Olympus;.
has a financial relationship (Other) with NIDDK;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Other) with Olympus;.
has a financial relationship (Independent contractor) with Olympus;.
has a financial relationship (Other) with NIDDK;.
has a financial relationship (Independent contractor) with Merck;.
Kenneth Mitchell, PA-C
has a financial relationship (Employment) with Metuchen Pharmaceuticals;.
has a financial relationship (Employment) with Metuchen Pharmaceuticals;.
has a financial relationship (Employment) with Metuchen Pharmaceuticals;.
has a financial relationship (Employment) with Metuchen Pharmaceuticals;.
Stanley Mukundi, PA-C
has no relevant financial relationships to disclose at this time.
Alana Murphy, MD
has no relevant financial relationships to disclose at this time.
Diane Newman, MD
has a financial relationship (Independent contractor) with Urovant;.
has a financial relationship (Employment) with UroToday;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Other) with Wellspect;.
has a financial relationship (Other) with NIH;.
has a financial relationship (Other) with Wellspect;.
has a financial relationship (Other) with NIH;.
has a financial relationship (Independent contractor) with Urovant;.
has a financial relationship (Employment) with UroToday;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Other) with Wellspect;.
has a financial relationship (Other) with NIH;.
has a financial relationship (Independent contractor) with Urovant;.
has a financial relationship (Employment) with UroToday;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with Urovant;.
has a financial relationship (Employment) with UroToday;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Other) with Wellspect;.
has a financial relationship (Other) with NIH;.
Jay Raman, MD
has a financial relationship (Independent contractor) with Urogen Pharma;.
has a financial relationship (Stock) with United Medical Systems, Inc.;.
has a financial relationship (Stock) with American Kidney Stone Management;.
has a financial relationship (Stock) with United Medical Systems, Inc.;.
has a financial relationship (Stock) with American Kidney Stone Management;.
has a financial relationship (Independent contractor) with Urogen Pharma;.
has a financial relationship (Stock) with American Kidney Stone Management;.
has a financial relationship (Independent contractor) with Urogen Pharma;.
has a financial relationship (Stock) with United Medical Systems, Inc.;.
has a financial relationship (Independent contractor) with Urogen Pharma;.
has a financial relationship (Stock) with United Medical Systems, Inc.;.
has a financial relationship (Stock) with American Kidney Stone Management;.
Ashleigh Renitsky, PA-C
has a financial relationship (Independent contractor) with Intuitive ;.
has a financial relationship (Independent contractor) with Intuitive ;.
has a financial relationship (Independent contractor) with Intuitive ;.
has a financial relationship (Independent contractor) with Intuitive ;.
Rachel Shapiro, PA
has a financial relationship (Independent contractor) with UroVant Sciences;.
has a financial relationship (Independent contractor) with UroVant Sciences;.
has a financial relationship (Independent contractor) with UroVant Sciences;.
has a financial relationship (Independent contractor) with UroVant Sciences;.
Sarah Stanley, MD
has no relevant financial relationships to disclose at this time.
Heidi Stephany, MD
has no relevant financial relationships to disclose at this time.
Benjamin Tackett
has no relevant financial relationships to disclose at this time.
Edouard Trabulsi, MD,MBA
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Pfizer ;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Pfizer ;.
has a financial relationship (Independent contractor) with Pfizer ;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Pfizer ;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with Janssen;.
Kevin Wayne, PA-C, BS, BA
has no relevant financial relationships to disclose at this time.
Gwendolyn Zilinskas, PA-C
has no relevant financial relationships to disclose at this time.
METHOD OF PARTICIPATION:
Learners will participate in this online educational activity by taking the pretest, viewing the webcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.
Estimated time to complete this activity: 14.00 hours
Release Date: June, 2020
Expiration Date: June, 2023
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this enduring activity for a maximum of 14.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
This webcast is complimentary to AUA Members.
Not an AUA member? Join today for access to this program!